121 related articles for article (PubMed ID: 25707423)
1. Cilostazol improves cognitive function in patients with mild cognitive impairment: a retrospective analysis.
Taguchi A; Takata Y; Ihara M; Kasahara Y; Tsuji M; Nishino M; Stern D; Okada M
Psychogeriatrics; 2013 Sep; 13(3):164-9. PubMed ID: 25707423
[TBL] [Abstract][Full Text] [Related]
2. Cilostazol add-on therapy in patients with mild dementia receiving donepezil: a retrospective study.
Ihara M; Nishino M; Taguchi A; Yamamoto Y; Hattori Y; Saito S; Takahashi Y; Tsuji M; Kasahara Y; Takata Y; Okada M
PLoS One; 2014; 9(2):e89516. PubMed ID: 24586841
[TBL] [Abstract][Full Text] [Related]
3. Diabetes augments cognitive dysfunction in chronic cerebral hypoperfusion by increasing neuronal cell death: implication of cilostazol for diabetes mellitus-induced dementia.
Kwon KJ; Lee EJ; Kim MK; Kim SY; Kim JN; Kim JO; Kim HJ; Kim HY; Han JS; Shin CY; Han SH
Neurobiol Dis; 2015 Jan; 73():12-23. PubMed ID: 25281785
[TBL] [Abstract][Full Text] [Related]
4. Cilostazol as an add-on therapy for patients with Alzheimer's disease in Taiwan: a case control study.
Tai SY; Chen CH; Chien CY; Yang YH
BMC Neurol; 2017 Feb; 17(1):40. PubMed ID: 28231822
[TBL] [Abstract][Full Text] [Related]
5. Effects of cilostazol on cognition and regional cerebral blood flow in patients with Alzheimer's disease and cerebrovascular disease: a pilot study.
Sakurai H; Hanyu H; Sato T; Kume K; Hirao K; Kanetaka H; Iwamoto T
Geriatr Gerontol Int; 2013 Jan; 13(1):90-7. PubMed ID: 22672107
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of Cilostazol in Mild Cognitive Impairment: A Randomized Clinical Trial.
Saito S; Suzuki K; Ohtani R; Maki T; Kowa H; Tachibana H; Washida K; Kawabata N; Mizuno T; Kanki R; Sudoh S; Kitaguchi H; Shindo K; Shindo A; Oka N; Yamamoto K; Yasuno F; Kakuta C; Kakuta R; Yamamoto Y; Hattori Y; Takahashi Y; Nakaoku Y; Tonomura S; Oishi N; Aso T; Taguchi A; Kagimura T; Kojima S; Taketsuna M; Tomimoto H; Takahashi R; Fukuyama H; Nagatsuka K; Yamamoto H; Fukushima M; Ihara M;
JAMA Netw Open; 2023 Dec; 6(12):e2344938. PubMed ID: 38048134
[TBL] [Abstract][Full Text] [Related]
7. Cognitive effects of cilostazol in Alzheimer's dementia patients with peripheral arterial occlusive disease: A case-control study.
Chien CF; Huang LC; Li KY; Yang YH
Geriatr Gerontol Int; 2023 Mar; 23(3):194-199. PubMed ID: 36682741
[TBL] [Abstract][Full Text] [Related]
8. [Study of the effects of vinpocetin on cognitive functions].
Valikovics A; Csányi A; Németh L
Ideggyogy Sz; 2012 Mar; 65(3-4):115-20. PubMed ID: 23136730
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of the phosphodiesterase III inhibitor cilostazol on amyloid β-induced cognitive deficits associated with decreased amyloid β accumulation.
Park SH; Kim JH; Bae SS; Hong KW; Lee DS; Leem JY; Choi BT; Shin HK
Biochem Biophys Res Commun; 2011 May; 408(4):602-8. PubMed ID: 21530492
[TBL] [Abstract][Full Text] [Related]
10. Design and Rationale for a Cognitive Outcome Substudy in Ischemic Stroke Patients with High Risk of Cerebral Hemorrhage.
Yu KH; Hong KS; Oh MS; Lee J; Lee JS; Kwon SU;
J Stroke Cerebrovasc Dis; 2016 Aug; 25(8):2061-6. PubMed ID: 27263034
[TBL] [Abstract][Full Text] [Related]
11. Cilostazol may improve cognition better than clopidogrel in non-surgical adult patients with ischemic moyamoya disease: subanalysis of a prospective cohort.
Ando S; Tsutsui S; Miyoshi K; Sato S; Yanagihara W; Setta K; Chiba T; Fujiwara S; Kobayashi M; Yoshida K; Kubo Y; Ogasawara K
Neurol Res; 2019 May; 41(5):480-487. PubMed ID: 30774013
[TBL] [Abstract][Full Text] [Related]
12. Effects of low blood pressure in cognitively impaired elderly patients treated with antihypertensive drugs.
Mossello E; Pieraccioli M; Nesti N; Bulgaresi M; Lorenzi C; Caleri V; Tonon E; Cavallini MC; Baroncini C; Di Bari M; Baldasseroni S; Cantini C; Biagini CA; Marchionni N; Ungar A
JAMA Intern Med; 2015 Apr; 175(4):578-85. PubMed ID: 25730775
[TBL] [Abstract][Full Text] [Related]
13. [Outcome and cognitive changes of mild cognitive impairment in the elderly: a follow-up study of 47 cases].
Xiao SF; Xue HB; Li GJ; Li CB; Wu WY; Zhang MY
Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(21):1441-6. PubMed ID: 16842692
[TBL] [Abstract][Full Text] [Related]
14. [Effects of ginkgo biloba tablet in treating mild cognitive impairment].
Dong ZH; Zhang CY; Pu BH
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Sep; 32(9):1208-11. PubMed ID: 23185760
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study.
Visser PJ; Verhey F; Knol DL; Scheltens P; Wahlund LO; Freund-Levi Y; Tsolaki M; Minthon L; Wallin AK; Hampel H; Bürger K; Pirttila T; Soininen H; Rikkert MO; Verbeek MM; Spiru L; Blennow K
Lancet Neurol; 2009 Jul; 8(7):619-27. PubMed ID: 19523877
[TBL] [Abstract][Full Text] [Related]
16. Dipeptidyl peptidase-4 inhibitors have protective effect on cognitive impairment in aged diabetic patients with mild cognitive impairment.
Rizzo MR; Barbieri M; Boccardi V; Angellotti E; Marfella R; Paolisso G
J Gerontol A Biol Sci Med Sci; 2014 Sep; 69(9):1122-31. PubMed ID: 24671867
[TBL] [Abstract][Full Text] [Related]
17. Analysis of outcome in retrieved dropout patients in a rivastigmine vs placebo, 26-week, Alzheimer disease trial.
Farlow M; Potkin S; Koumaras B; Veach J; Mirski D
Arch Neurol; 2003 Jun; 60(6):843-8. PubMed ID: 12810489
[TBL] [Abstract][Full Text] [Related]
18. Effect of baseline cognitive function and antihypertensive treatment on cognitive and cardiovascular outcomes: Study on COgnition and Prognosis in the Elderly (SCOPE).
Skoog I; Lithell H; Hansson L; Elmfeldt D; Hofman A; Olofsson B; Trenkwalder P; Zanchetti A;
Am J Hypertens; 2005 Aug; 18(8):1052-9. PubMed ID: 16109319
[TBL] [Abstract][Full Text] [Related]
19. The assessment of cognitive impairment suspected of dementia in Polish elderly people: results of the population-based PolSenior Study.
Klich-Rączka A; Piotrowicz K; Mossakowska M; Skalska A; Wizner B; Broczek K; Wieczorowska-Tobis K; Grodzicki T
Exp Gerontol; 2014 Sep; 57():233-42. PubMed ID: 24937034
[TBL] [Abstract][Full Text] [Related]
20. Effect of Memo®, a natural formula combination, on Mini-Mental State Examination scores in patients with mild cognitive impairment.
Yakoot M; Salem A; Helmy S
Clin Interv Aging; 2013; 8():975-81. PubMed ID: 23950642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
